Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

890 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world outcomes of PARP inhibitor maintenance in advanced ovarian cancer: a focus on disease patterns and treatment modalities at recurrence.
Loverro M, Marchetti C, Salutari V, Giannarelli D, Vertechy L, Capomacchia FM, Caricato C, Campitelli M, Panico C, Avesani G, Cocciolillo F, Rosati A, Scambia G, Fagotti A. Loverro M, et al. Among authors: marchetti c. ESMO Open. 2025 Jan 17;10(2):104119. doi: 10.1016/j.esmoop.2024.104119. Online ahead of print. ESMO Open. 2025. PMID: 39826478 Free article.
Actionable mutations in early-stage ovarian cancer according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT): a descriptive analysis on a large prospective cohort.
Camarda F, Mastrantoni L, Parrillo C, Minucci A, Persiani F, Giannarelli D, Pasciuto T, Giacomini F, De Paolis E, Manfredelli M, Marchetti C, Zannoni GF, Fagotti A, Scambia G, Nero C. Camarda F, et al. Among authors: marchetti c. ESMO Open. 2024 Dec 19;10(1):104090. doi: 10.1016/j.esmoop.2024.104090. Online ahead of print. ESMO Open. 2024. PMID: 39705839 Free PMC article.
Stereotactic Ablative Radiation Therapy for Oligometastatic Ovarian Cancer Lymph Node Disease: The MITO-RT3/RAD Phase II Trial.
Macchia G, Campitelli M, Pezzulla D, Lucci S, Fodor A, Russo D, Balcet V, Bonome P, Durante S, Draghini L, Titone F, D'Agostino GR, Tamburo M, Ferioli M, Ippolito E, Tortoreto F, Caravatta L, De Felice F, Stefano AD, Fanelli M, Cilla S, Cosentino F, Marchetti C, Salutari V, Boccia S, Morganti AG, Gambacorta MA, Fagotti A, Pignata S, Scambia G, Ferrandina G, Deodato F. Macchia G, et al. Among authors: marchetti c. Int J Radiat Oncol Biol Phys. 2024 Sep 24:S0360-3016(24)03402-3. doi: 10.1016/j.ijrobp.2024.09.036. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39326506
Stereotactic Body Radiation Therapy for Oligoprogressive Ovarian Cancer Patients Treated During Poly(ADP-Ribose)-Polymerase Inhibitor Maintenance: Efficacy and Adverse Events From the Epimetheo Retrospective Study.
Macchia G, Pezzulla D, Campitelli M, Russo D, Ronzino G, Lucci S, Salutari V, Di Stefano A, Balcet V, Epifani V, Perrucci E, Marchetti C, Distefano MG, Palluzzi E, Autorino R, De Luca V, Giannini R, Rinaldi R, Russo SA, Cilla S, Fagotti A, Gambacorta MA, Scambia G, Deodato F, Ferrandina G. Macchia G, et al. Among authors: marchetti c. Int J Radiat Oncol Biol Phys. 2025 Feb 1;121(2):465-474. doi: 10.1016/j.ijrobp.2024.09.010. Epub 2024 Sep 8. Int J Radiat Oncol Biol Phys. 2025. PMID: 39255875
Parkinson's Disease Gene Screening in Familial Cases from Central and South America.
Lorenzo-Betancor O, Mehta S, Ramchandra J, Mumuney S, Schumacher-Schuh AF, Cornejo-Olivas M, Sarapura-Castro EH, Torres L, Inca-Martinez MA, Mazzetti P, Cosentino C, Micheli F, Tumas V, Dieguez E, Raggio V, Borges V, Ferraz HB, Chana-Cuevas P, Jimenez-Del-Rio M, Velez-Pardo C, Moreno S, Lopera F, Orozco-Velez JL, Muñoz-Ospina B, Rieder CRM, Medina-Escobar A, Yearout D, Zabetian CP, Mata IF; Latin American Research Consortium on the Genetics of PD (LARGE‐PD). Lorenzo-Betancor O, et al. Mov Disord. 2024 Oct;39(10):1843-1855. doi: 10.1002/mds.29931. Epub 2024 Jul 25. Mov Disord. 2024. PMID: 39051491
890 results